This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Mion G. History of anaesthesia: The ketamine story - past, present and future. Eur J Anaesthesiol. 2017; 34: 571–575.MionGHistory of anaesthesia: The ketamine story - past, present and future20173457157510.1097/EJA.000000000000063828731926Search in Google Scholar
Ilkjaer S, Petersen KL, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth. 1996; 76: 829–834.IlkjaerSPetersenKLBrennumJWernbergMDahlJBEffect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans19967682983410.1093/bja/76.6.8298679358Search in Google Scholar
Wachtel H, Turski L. Glutamate: A new target in schizophrenia? Trends Pharmacol Sci. 1990; 11: 219–220.WachtelHTurskiLGlutamate: A new target in schizophrenia?19901121922010.1016/0165-6147(90)90243-22166367Search in Google Scholar
Gosek P, Chojnacka M, Bieńkowski P, Świecicki Ł. Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy. Psychiatr Pol. 2014; 48: 49–58.GosekPChojnackaMBieńkowskiPŚwiecickiŁEffectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy201448495810.12740/PP/20566Search in Google Scholar
Schwartz J, Murrough JW, Iosifescu DV. Ketamine for treatment-resistant depression: Recent developments and clinical applications. Evid Based Ment Health. 2016; 19: 35–38.SchwartzJMurroughJWIosifescuDVKetamine for treatment-resistant depression: Recent developments and clinical applications201619353810.1136/eb-2016-10235527053196Search in Google Scholar
Serafini G, Howland R, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: A systematic review. Curr Neuropharmacol. 2014; 12: 444–461.SerafiniGHowlandRRovediFGirardiPAmoreMThe role of ketamine in treatment-resistant depression: A systematic review20141244446110.2174/1570159X12666140619204251424303425426012Search in Google Scholar
Bobo WV, Voort JLV, Croarkin PE, Leung JG, Tye SJ, Frye MA. Ketamine for treatment-resistant unipolar and bipolar major depression: Critical review and implications for clinical practice. Depress Anxiety. 2016; 33: 698–710.BoboWVVoortJLVCroarkinPELeungJGTyeSJFryeMAKetamine for treatment-resistant unipolar and bipolar major depression: Critical review and implications for clinical practice20163369871010.1002/da.2250527062450Search in Google Scholar
Nowak W, Grendas LN, Sanmarco LM, Estecho IG, Arena ÁR, Eberhardt N, Rodante DE, Aoki MP, Daray FM, Carrera Silva EA, Errasti AE. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR. EBioMedicine. 2019; 50: 290–305.NowakWGrendasLNSanmarcoLMEstechoIGArenaÁREberhardtNRodanteDEAokiMPDarayFMCarrera SilvaEAErrastiAEPro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR20195029030510.1016/j.ebiom.2019.10.063692122631753725Search in Google Scholar
Szałach ŁP, Lisowska KA, Cubała WJ. The influence of antidepressants on the immune system. Arch Immunol Ther Exp. 2019; 67: 143–151.SzałachŁPLisowskaKACubałaWJThe influence of antidepressants on the immune system20196714315110.1007/s00005-019-00543-8650909331032529Search in Google Scholar
Begec Z, Yucel A, Yakupogullari Y, Erdogan MA, Duman Y, Durmus M, Ersoy MO. The antimicrobial effects of ketamine combined with propofol: An in vitro study. Braz J Anesthesiol. 2013; 63: 461–465.BegecZYucelAYakupogullariYErdoganMADumanYDurmusMErsoyMOThe antimicrobial effects of ketamine combined with propofol: An in vitro study20136346146510.1016/j.bjane.2012.09.00424565343Search in Google Scholar
Gocmen S, Buyukkocak U, Caglayan O. In vitro investigation of the antibacterial effect of ketamine. Ups J Med Sci. 2008; 113: 39–46.GocmenSBuyukkocakUCaglayanOIn vitro investigation of the antibacterial effect of ketamine2008113394610.3109/2000-1967-21118521797Search in Google Scholar
Kruszewska H, Zareba T, Tyski S. Search of antimicrobial activity of selected non-antibiotic drugs. Acta Pol Pharm. 2002; 59: 436–439.KruszewskaHZarebaTTyskiSSearch of antimicrobial activity of selected non-antibiotic drugs200259436439Search in Google Scholar
Anders HJ, Lichtnekert J, Allam R. Interferon-α and -β in kidney inflammation. Kidney Int. 2010; 77: 848–854.AndersHJLichtnekertJAllamRInterferon-α and -β in kidney inflammation20107784885410.1038/ki.2010.7120237459Search in Google Scholar
Doss SA, Tillotson GS, Amyes SGB. Effect of sub-inhibitory concentrations of antibiotics on the virulence of Staphylococcus aureus. J Appl Bacteriol. 1993; 75: 123–128.DossSATillotsonGSAmyesSGBEffect of sub-inhibitory concentrations of antibiotics on the virulence of Staphylococcus aureus19937512312810.1111/j.1365-2672.1993.tb02756.x8407672Search in Google Scholar
Hacker J, Ott M, Hof H. Effects of low, subinhibitory concentrations of antibiotics on expression of a virulence gene cluster of pathogenic Escherichia coli by using a wild-type gene fusion. Int J Antimicrob Agents. 1993; 2: 263–270.HackerJOttMHofHEffects of low, subinhibitory concentrations of antibiotics on expression of a virulence gene cluster of pathogenic Escherichia coli by using a wild-type gene fusion1993226327010.1016/0924-8579(93)90060-I18611540Search in Google Scholar
Lück PC, Schmitt JW, Hengerer A, Helbig JH. Subinhibitory concentrations of antimicrobial agents reduce the uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 cells by altering the expression of virulence-associated antigens. Antimicrob Agents and Chemother. 1998; 42: 2870–2876.LückPCSchmittJWHengererAHelbigJHSubinhibitory concentrations of antimicrobial agents reduce the uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 cells by altering the expression of virulence-associated antigens1998422870287610.1128/AAC.42.11.28701059589797218Search in Google Scholar
Nichterlein T, Domann E, Kretschmar M, Bauer M, Hlawatsch A, Hof H, Chakraborty T. Subinhibitory concentrations of β-lactams and other cell-wall antibiotics inhibit listeriolysin production by Listeria monocytogenes. Int J of Antimicrob Agents. 1996; 7: 75–81.NichterleinTDomannEKretschmarMBauerMHlawatschAHofHChakrabortyTSubinhibitory concentrations of β-lactams and other cell-wall antibiotics inhibit listeriolysin production by Listeria monocytogenes19967758110.1016/0924-8579(96)00014-318611740Search in Google Scholar
Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate Jr CA, et al. Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacol Rev. 2018; 70: 621–660.ZanosPMoaddelRMorrisPJRiggsLMHighlandJNGeorgiouPPereiraEFRAlbuquerqueEXThomasCJZarateCAJrKetamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms20187062166010.1124/pr.117.015198602010929945898Search in Google Scholar
Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y. Ketamine interactions with gut-microbiota in rats: Relevance to its antidepressant and anti-inflammatory properties. BMC Microbiol. 2018; 18: 222.GetachewBAubeeJISchottenfeldRSCsokaABThompsonKMTizabiYKetamine interactions with gut-microbiota in rats: Relevance to its antidepressant and anti-inflammatory properties20181822210.1186/s12866-018-1373-7630395430579332Search in Google Scholar
Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013; 11: 200.BerkMWilliamsLJJackaFNO’NeilAPascoJAMoylanSAllenNBStuartALHayleyACByrneMLMaesMSo depression is an inflammatory disease, but where does the inflammation come from?20131120010.1186/1741-7015-11-200384668224228900Search in Google Scholar
Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies. Biol Psychiatry. 2013; 74: 15–25.ModabberniaATaslimiSBrietzkeEAshrafiMCytokine alterations in bipolar disorder: A meta-analysis of 30 studies201374152510.1016/j.biopsych.2013.01.00723419545Search in Google Scholar
Zarate CA, Brutsche N, Laje G, Luckenbaugh DA, Venkata SLV, Ramamoorthy A, Moaddel R, Wainer IW. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry. 2012; 72: 331–338.ZarateCABrutscheNLajeGLuckenbaughDAVenkataSLVRamamoorthyAMoaddelRWainerIWRelationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression20127233133810.1016/j.biopsych.2012.03.004344225522516044Search in Google Scholar
Strohalm M, Hassman M, Košata B, Kodíček M. mMass data miner: An open source alternative for mass spectrometric data analysis. Rapid Commun Mass Spectrom. 2008; 22: 905–908.StrohalmMHassmanMKošataBKodíčekMmMass data miner: An open source alternative for mass spectrometric data analysis20082290590810.1002/rcm.344418293430Search in Google Scholar
Stępień-Pyśniak D, Hauschild T, Różański P, Marek A. MALDI-TOF mass spectrometry as a useful tool for identification of Enterococcus spp. from wild birds and differentiation of closely related species. J Microbiol Biotechnol. 2017; 27: 1128–1137.Stępień-PyśniakDHauschildTRóżańskiPMarekAMALDI-TOF mass spectrometry as a useful tool for identification of Enterococcus spp. from wild birds and differentiation of closely related species2017271128113710.4014/jmb.1612.1203628285496Search in Google Scholar
Chan KL, Cathomas F, Russo SJ. Central and peripheral inflammation link metabolic syndrome and major depressive disorder. Physiology. 2019; 34: 123–133.ChanKLCathomasFRussoSJCentral and peripheral inflammation link metabolic syndrome and major depressive disorder20193412313310.1152/physiol.00047.2018658683230724127Search in Google Scholar
Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018; 23: 801–811.ZanosPGouldTDMechanisms of ketamine action as an antidepressant20182380181110.1038/mp.2017.255599940229532791Search in Google Scholar
Comerlato CB, Zhang X, Walker K, Brandelli A, Figeys D. Comparative proteomic analysis reveals metabolic variability of probiotic Enterococcus durans during aerobic and anaerobic cultivation. J Proteomics. 2020; 220: 103764.ComerlatoCBZhangXWalkerKBrandelliAFigeysDComparative proteomic analysis reveals metabolic variability of probiotic Enterococcus durans during aerobic and anaerobic cultivation202022010376410.1016/j.jprot.2020.10376432247174Search in Google Scholar
Toyota S, Moriyama M, Otake T, Kono J, Shudou Y, Satake T, Seki K, Masuda S, Amaki Y. Effect of anaesthetic agents on the phagocytic function of human polymorphonuclear leukocytes through analysis with a phagocytic plaque method. Inflamm Res. 1995; 44: 204–206.ToyotaSMoriyamaMOtakeTKonoJShudouYSatakeTSekiKMasudaSAmakiYEffect of anaesthetic agents on the phagocytic function of human polymorphonuclear leukocytes through analysis with a phagocytic plaque method19954420420610.1007/BF017822597655994Search in Google Scholar
Krumholz W, Endrass J, Hempelmann G. Inhibition of phagocytosis and killing of bacteria by anaesthetic agents in vitro. Br J Anaesth. 1995; 75: 66–70.KrumholzWEndrassJHempelmannGInhibition of phagocytosis and killing of bacteria by anaesthetic agents in vitro199575667010.1093/bja/75.1.667669473Search in Google Scholar
Son KA, Kang JH, Yang MP. Ketamine inhibits the phagocytic responses of canine peripheral blood polymorphonuclear cells through the upregulation of prostaglandin E2 in peripheral blood mononuclear cells in vitro. Res Vet Sci. 2009; 87: 41–46.SonKAKangJHYangMPKetamine inhibits the phagocytic responses of canine peripheral blood polymorphonuclear cells through the upregulation of prostaglandin E2 in peripheral blood mononuclear cells in vitro200987414610.1016/j.rvsc.2008.12.00419167017Search in Google Scholar